FG
GSK icon

Foster Group’s GSK GSK Stock Holding History

Foster Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+3,875
New +$205K 0.01% 304

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

Foster Group's GSK Position: Q2 2026 in Review

Foster Group opened a new position in GSK (GSK) in Q2 2026: 3,875 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #304 among its holdings.

161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Foster Group held 3,875 shares of GSK worth $203K as of Q2 2026.
  • GSK was a new Foster Group position in Q2 2026.
  • GSK made up 0.01% of Foster Group's portfolio in Q2 2026, its #304 holding.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.